Please provide your email address to receive an email when new articles are posted on . WASHINGTON — A model predicting the development of systemic lupus erythematosus, based on genetic, lifestyle and ...
CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that it will be presenting data from preclinical studies of its Toll-like receptor (TLR) inhibitor, ...
Credit ISM / Pr J.L. KEMENY For Arthritis Awareness Month, Paul Hoover, MD, and colleagues provide insight into the research conducted by their team on understanding human lupus nephritis mechanisms ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results